Healthcare Execs Face Federal Drug Charges in Landmark Telehealth Case

In a first-of-its-kind prosecution, federal prosecutors have charged two healthcare executives with unlawfully distributing controlled substances, such as Adderall, through a telehealth website. These charges demonstrate the Department of Justice’s intensified focus on enforcing federal controlled substances laws in the rapidly evolving digital health landscape….
By: Bradley Arant Boult Cummings LLP
Previous Story

Hong Kong proposes new Critical Infrastructure Cybersecurity Law

Next Story

Chinese Antitrust Enforcement Agency Issues Warning Letter to Patent Pool